Long COVID in the skin: a registry analysis of COVID-19 dermatological duration

Since the start of the COVID-19 pandemic, multiple studies have reported that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with dermatological manifestations.1 However, data on duration of signs and symptoms for the myriad dermatological manifestations of COVID-19 are l...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet infectious diseases 2021-03, Vol.21 (3), p.313-314
Main Authors: McMahon, Devon E, Gallman, Antonia E, Hruza, George J, Rosenbach, Misha, Lipoff, Jules B, Desai, Seemal R, French, Lars E, Lim, Henry, Cyster, Jason G, Fox, Lindy P, Fassett, Marlys S, Freeman, Esther E
Format: Article
Language:English
Subjects:
Adult
Comment
Coronaviruses
COVID-19
COVID-19 - diagnosis
COVID-19 - immunology
COVID-19 - pathology
COVID-19 - virology
Dermatology
Female
Humans
Infectious diseases
Laboratories
Male
Middle Aged
Morbidity
Pandemics
Patients
SARS-CoV-2 - isolation & purification
Severe acute respiratory syndrome
Severe acute respiratory syndrome coronavirus 2
Signs and symptoms
Skin
Skin - virology
Skin Diseases - diagnosis
Skin Diseases - immunology
Skin Diseases - pathology
Skin Diseases - virology
Viral diseases
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Since the start of the COVID-19 pandemic, multiple studies have reported that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with dermatological manifestations.1 However, data on duration of signs and symptoms for the myriad dermatological manifestations of COVID-19 are lacking. [...]58% of providers reported that patients had ongoing COVID-19 dermatological manifestations at the time of case entry. [...]the duration of dermatological manifestations reported here probably underestimates both average duration and the number of long-hauler patients. Since the onset of the COVID-19 pandemic, appreciation for persistent morbidity beyond the acute phase of disease has increased.4,10 To our knowledge, our data represent the largest dataset to date on persistent skin signs and symptoms of COVID-19 and the duration for several distinct skin manifestations.
ISSN:1473-3099
1474-4457
DOI:10.1016/S1473-3099(20)30986-5